Head-to-head · WeighScore
eMed vs GOAL.MD
The verdict
GOAL.MD takes it — 68.4/100 to 57.4/100.
GOAL.MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | eMed | GOAL.MD |
|---|---|---|
| WeighScore | 57.4/100 | 68.4/100 |
| Grade | C | C |
| Scorecard rank | #399 | #151 |
| Semaglutide | Not disclosed | $179/mo |
| Tirzepatide | Not disclosed | $249/mo (starting dose, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #399 · C
Strengths
- Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
- At-home blood collection makes lab work convenient
- Clinician review and ongoing side-effect plus adherence support
- Works with CVS Caremark so eligible employees can buy through benefits
- Established digital health company with national scale
Where it loses points
- Distributed mainly via employers, with limited direct cash-pay access
- No public transparent monthly price for individuals
- Eligibility and subsidy depend on what the employer chooses to cover
- Best suited to workforces, not casual self-pay shoppers
Graded #151 · C
Strengths
- Transparent dose-tiered pricing on brand pens
- LegitScript Certified
- Manual-renewal model — no surprise auto-billing
- Free nutrition coach included
- BBB A+ rating since 2021
Where it loses points
- No named compounding pharmacy partner
- Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
- No URAC or PCAB pharmacy accreditation
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.